semaglutide api market Size, Share, Opportunity, Growth, 2034 Semaglutide Market Size & Share,

Direct Nerve Stimulation Since the gut may not be absorbing nutrients well (a side effect of GLP-1s), we must bypass the gut

Since it increases urine frequency, taking it during the day is better

Zepbound, also known by its generic name tirzepatide, is a medication approved for weight management in adults with obesity or overweight individuals who have weight-related health issues

This can lead to cardiovascular disease, increasing the risk of heart attack and stroke

Potential Risks and Gastrointestinal Side Effects GLP-1 medications slow gastric emptying and gut motilitya mechanism that promotes satiety but can cause nausea, vomiting, constipation, and abdominal discomfort in some users